Skip to main content
Veterinary Medicines

Tabic V.H. tabletki musujące dla kur i indyków

Authorised
  • Newcastle disease virus, strain V.H., Live

Product identification

Medicine name:
Tabic V.H. tabletki musujące dla kur i indyków
Active substance:
  • Newcastle disease virus, strain V.H., Live
Target species:
  • Chicken (hen)
  • Turkey
Route of administration:
  • Nebulisation use
  • In drinking water use

Product details

Active substance and strength:
  • Newcastle disease virus, strain V.H., Live
    1000000.00
    50% Embryo Infective Dose
    /
    1.00
    Tablet
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken (hen)
      • All relevant tissues
        0
        day
    • Turkey
      • All relevant tissues
        0
        day
  • In drinking water use
    • Chicken (hen)
      • All relevant tissues
        0
        day
    • Turkey
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
  • QI01CD
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Synoptis Industrial Sp. z o.o.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1694
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 6/02/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 13/08/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 13/08/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."